FTRE Company Profile and Key Details

NASDAQ : FTRE

Fortrea

$17.58

0.18+1.03%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Fortrea Holdings Inc. (FTRE) stock surged +1.03%, trading at $17.58 on NASDAQ, up from the previous close of $17.40. The stock opened at $17.70, fluctuating between $17.38 and $18.34 in the recent session.

Stock Snapshot

17.4

Prev. Close

1.66B

Market Cap

17.38

Day Low

31.39

P/E Ratio

0.56

EPS (TTM)

N/A

Cash Flow per Share

17.7

Open

94.58M

Number of Shares

18.34

Day High

92.38%

Free Float in %

N/A

Book Value

1.51M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 01, 2026	17.70	18.34	17.38	17.58	1.57M
Jun 30, 2026	17.53	17.75	17.24	17.40	1.08M
Jun 29, 2026	17.52	17.80	17.09	17.52	1.21M
Jun 26, 2026	16.97	17.85	16.52	17.65	3.63M
Jun 25, 2026	17.05	18.16	16.99	17.71	1.92M
Jun 24, 2026	16.83	17.78	16.75	17.02	2.47M
Jun 23, 2026	15.37	16.52	15.25	16.46	1.17M
Jun 22, 2026	15.69	15.99	15.20	15.56	1.73M
Jun 18, 2026	15.76	16.05	14.88	15.31	3.01M
Jun 17, 2026	15.90	16.04	15.23	15.32	1.09M
Jun 16, 2026	16.67	16.69	15.90	15.98	1.47M
Jun 15, 2026	16.71	17.08	16.38	16.63	948.7K
Jun 12, 2026	16.75	16.95	16.40	16.48	964.66K
Jun 11, 2026	16.49	17.07	16.15	16.87	1.24M
Jun 10, 2026	16.91	17.24	16.32	16.34	1.05M
Jun 09, 2026	17.00	17.34	16.08	16.88	866.74K
Jun 08, 2026	16.42	17.20	16.22	16.57	1.19M
Jun 05, 2026	17.03	17.49	15.99	16.08	1.03M
Jun 04, 2026	15.68	17.56	15.55	17.25	2.99M
Jun 03, 2026	15.36	15.65	14.47	15.63	998.15K

Contact Details

Durham, NC 27709

United States

https://www.fortrea.com 480 295 7600

About Company

Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.

Stock Peers

ARGX

-18.27-1.97%

argenx SE$909.50 REGN

1.18+0.19%

Regeneron Pharmaceuticals, Inc.$624.72 UTHR

5.32+0.98%

United Therapeutics Corporation$547.15 MDGL

-22.56-4.20%

Madrigal Pharmaceuticals, Inc.$514.39 VRTX

1.28+0.26%

Vertex Pharmaceuticals Incorporated$498.01 KRYS

-0.09-0.02%

Krystal Biotech, Inc.$371.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-15.19-4.54%

Praxis Precision Medicines, Inc.$319.60 LGND

-4.08-1.29%

Ligand Pharmaceuticals Incorporated$312.01 ALNY

0.64+0.21%

Alnylam Pharmaceuticals, Inc.$301.67

Company Overview

Fortrea Holdings Inc. (NASDAQ:FTRE) closed at $17.58 USD, gaining $0.18 (1.03%) from the previous close of $17.40. The stock is currently mid-range between its 52-week high and low $4.36 and $18.67. With a market capitalization of about $1.66 billion, Fortrea Holdings Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~2.11). Key stats such as the average daily volume over the past year has been around 1.42 million shares, in line with its 52-week average. Headquartered in Durham, NC, Fortrea Holdings Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Anshul Thakral, the company employs approximately 15,000 people and listed since June 20, 2023. Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -15.67%, SMA50 -29.64%, SMA200 7.4%). The stock’s 14-day RSI is 34.62 (weak momentum), while the ATR of 1.19 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -42.15% below its high and over 172.04% above its low. Average 10-day trading volume of 1.85 million shares is slightly above the 3-month average of 1.43 million, indicating heightened recent market interest.

Valuation Metrics

Fortrea Holdings Inc. trades at a P/E ratio of -3.58, slightly below the S&P 500 average, with a price-to-sales ratio of 0.62 and a price-to-book ratio of 3.06 trading at moderately above to book value. The P/FCF stands at 8.76, also above market averages.

Dividend & Fair Value

Fortrea Holdings Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.93. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Fortrea Holdings Inc. generated EPS of -$11.28 over the past year. Five-year average earnings growth is 3.94%. Wall Street analysts project EPS growth of 47.15% annually over the next five years. Analyst sentiment is neutral. Analyst rating data shows there are 5 Strong Buy ratings, 4 Buy ratings, 14 Hold ratings, 0 Sell rating and 3 Strong Sell ratings. Price targets range from $25.00 to $5.00. The high target offers 42.21% upside. The low target suggests -71.56% downside. The mean target is $13.37. This offers -23.95% upside. Fortrea Holdings Inc. earnings surprise history is a mixed track record. The quarter that ended May 05, 2026, missed forecasts by 433.33%. The prior quarter beat by -43.75%. Over the last six quarters, Apple has recorded several small beats. These include -50.0% in March 03, 2025.

Shareholding & Insider Activity

Fortrea Holdings Inc. has 90.80 million shares outstanding. The public float is 83.92 million shares, elevated short interest at 21.65% of float. This equals 12.94 million shares. The short ratio is 6.92 days. Institutional investors hold 111.8% of the float. Insiders own 0.49%. Pike Thomas holds 159.87 thousand shares, Mcconnell Jill G. has 72.28 thousand shares and Morais Mark A. has 71.36 thousand shares. Over the past six months, insider transactions show net selling. They sold 17.11 thousand shares across 9 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Fortrea has not generated any revenue.
On valuation metrics, Fortrea trades at a P/E of -3.58, P/S of 0.62 and P/B of 3.06. Liquidity is tight, with a current ratio of 0.95 and quick ratio of 0.95. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 72.14 days. Debt-to-equity is 2.13, supported by a cash flow-to-debt ratio of 0.20.

Price Forecast & Outlook

Our AI price prediction model suggests that Fortrea Holdings Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.15%, with price expected at $18.31 by July 14, 2026, within a range of $17.27 to $19.44 3-Month Outlook: Projected rise of 14.62%, reaching $20.15 by September 28, 2026, with a range of $17.93 to $21.63. 1-Year Outlook: Projected loss of -49.26%, with price at $8.92 by June 30, 2027, within a range of $6.89 to $11.24.

Key Takeaways

Fortrea Holdings Inc. (NASDAQ:FTRE) shares are flat -8.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Fortrea Holdings Inc. trading at a premium to the broader market with a P/E of -3.58. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $16.71, suggesting -4.95% downside. Our AI forecast model points to short-term strength (4.15% over two weeks), a medium-term rise (14.62% over three months), and a longer-term loss (-49.26% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Fortrea Holdings Inc. (FTRE) stock price?

Fortrea Holdings Inc. (NASDAQ: FTRE) stock price is $17.58 in the last trading session. During the trading session, FTRE stock reached the peak price of $18.34 while $17.38 was the lowest point it dropped to. The percentage change in FTRE stock occurred in the recent session was 1.03% while the dollar amount for the price change in FTRE stock was $0.18.

FTRE's industry and sector of operation?

The NASDAQ listed FTRE is part of Biotechnology industry that operates in the broader Healthcare sector. Fortrea Holdings Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of FTRE?

No Data

How FTRE did perform over past 52-week?

FTRE's closing price is 303.67% higher than its 52-week low of $4.36 where as its distance from 52-week high of $18.67 is -5.84%.

How many employees does FTRE have?

Number of FTRE employees currently stands at 15,000.

Link for FTRE official website?

Official Website of FTRE is: https://www.fortrea.com

How do I contact FTRE?

FTRE could be contacted at phone 480 295 7600 and can also be accessed through its website. FTRE operates from 8 Moore Drive, Durham, NC 27709, United States.

How many shares of FTRE are traded daily?

FTRE stock volume for the day was 1.51M shares. The average number of FTRE shares traded daily for last 3 months was 1.42M.

What is the market cap of FTRE currently?

The market value of FTRE currently stands at $1.66B with its latest stock price at $17.58 and 94.58M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	15000
Beta	2.11
Sales or Revenue	N/A
5Y Sales Change%	0.097%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

FTRE Company Profile and Key Details

Fortrea

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Company Overview

Shareholding & Insider Activity

Valuation Metrics

Earnings & Analyst Outlook

Financial & Profitability Overview

Key Takeaways

Price Forecast & Outlook